Distinct Effects of the Cervicovaginal Microbiota and Herpes Simplex Type 2 Infection on Female Genital Tract Immunology

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Infectious Diseases

• Publication date

  2017-05-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1093/infdis/jix088PMID 28201724PMCID PMC5451606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immune Activation in the Female Genital Tract: Expression Profiles of Soluble Proteins in Women at High Risk for HIV Infection

  2016cited by this paper
• Genital inflammation and the risk of HIV acquisition in women.

  2015cited by this paper
• Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier

  2015cited by this paper
• Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention

  2015influential reference
• Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells

  2015influential reference
• Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract.

  2015influential reference
• Inflammation and HIV Transmission in Sub-Saharan Africa

  2015cited by this paper
• Identification of preferential CD4+ T-cell targets for HIV infection in the cervix

  2015cited by this paper
• Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study

  2014influential reference
• Impact of Asymptomatic Herpes Simplex Virus Type 2 Infection on Mucosal Homing and Immune Cell Subsets in the Blood and Female Genital Tract

  2014cited by this paper
• The Vaginal Microbiota: What Have We Learned after a Decade of Molecular Characterization?

  2014cited by this paper
• Cytokines and mucosal immunity

  2014cited by this paper
• An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform

  2014cited by this paper
• Estimating per-act HIV transmission risk: a systematic review

  2014cited by this paper
• The epidemiology of sexually transmitted co-infections in HIV-positive and HIV-negative African-Caribbean women in Toronto

  2013cited by this paper
• Commensal bacteria at the interface of host metabolism and the immune system

  2013cited by this paper
• Temporal Dynamics of the Human Vaginal Microbiota

  2012cited by this paper
• Impact of asymptomatic Herpes simplex virus-2 infection on T cell phenotype and function in the foreskin

  2012cited by this paper
• BactQuant: An enhanced broad-coverage bacterial quantitative real-time PCR assay

  2012cited by this paper
• A framework for human microbiome research

  2012cited by this paper
• Pathogenic mechanisms of HIV disease.

  2011cited by this paper
• Performance of Commercial Herpes Simplex Virus Type-2 Antibody Tests Using Serum Samples From Sub-Saharan Africa: A Systematic Review and Meta-analysis

  2011cited by this paper
• Biological Factors that May Contribute to Regional and Racial Disparities in HIV Prevalence

  2011cited by this paper
• Characterization of a Human Cervical CD4+ T Cell Subset Coexpressing Multiple Markers of HIV Susceptibility

  2011influential reference
• Intravaginal Practices, Bacterial Vaginosis, and HIV Infection in Women: Individual Participant Data Meta-analysis

  2011cited by this paper
• Vaginal microbiome of reproductive-age women

  2010influential reference
• Exposure to HIV-1 Directly Impairs Mucosal Epithelial Barrier Integrity Allowing Microbial Translocation

  2010cited by this paper
• Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies.

  2009cited by this paper
• Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli.

  2009cited by this paper
• Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition

  2009cited by this paper
• The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission.

  2008cited by this paper
• Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.

  2008cited by this paper
• Genital levels of soluble immune factors with anti-HIV activity may correlate with increased HIV susceptibility.

  2008cited by this paper
• Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract

  2007cited by this paper
• Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies

  2007cited by this paper
• Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections.

  2007cited by this paper
• High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence.

  2006cited by this paper
• Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies

  2006cited by this paper
• Induction of tumor necrosis factor- alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis.

  2005cited by this paper
• Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis.

  2005cited by this paper
• HIV and sexually transmitted diseases: lethal synergy.

  2004cited by this paper
• Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial.

  2004cited by this paper
• Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis.

  2003cited by this paper
• Clinical and Cervical Cytokine Response to Treatment With Oral or Vaginal Metronidazole for Bacterial Vaginosis During Pregnancy: A Randomized Trial

  2003cited by this paper
• Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review.

  2002cited by this paper
• Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation

  1991cited by this paper

• Post-coital dynamics of the penile and cervico-vaginal genital microbiome.

  2026cites this paper
• Mapping Cervical Microbiome Diversity and Inflammatory Milieu and Its Perturbation in Asymptomatic Bacterial Vaginosis and Candida Infections: Insights from a Community Clinic in Mumbai.

  2026cites this paper
• Lactic acid produced by optimal vaginal Lactobacillus spp. potently and specifically inactivates HIV-1 in vitro by targeting the viral RNA genome and reverse transcriptase

  2025cites this paper
• Interactions between bacterial vaginosis-associated microbiota and Trichomonas vaginalis modulate parasite-induced pathogenicity and host immune responses

  2025cites this paper
• Cytokine concentration and T cell subsets in the female genital tract in the presence of bacterial vaginosis and Trichomonas vaginalis

  2025cites this paper
• Microbiome–Maternal Tract Interactions in Women with Recurrent Implantation Failure

  2025cites this paper
• Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial

  2025cites this paper
• Bacterial vaginosis associates with dysfunctional T cells and altered soluble immune factors in the cervicovaginal tract

  2025cites this paper
• All Properties of Infertility Microbiome in a Review Article

  2025cites this paper
• Quantitative profiling of the vaginal microbiota improves resolution of the microbiota-immune axis

  2025cites this paper
• Bacterial vaginosis is associated with transcriptomic changes but not higher concentrations of cervical leukocytes in a study of women at high risk for HIV acquisition.

  2025cites this paper
• Gardnerella vaginalis-binding IgA in the urethra of sexually experienced males

  2025cites this paper
• Microbial regulators of physiological and reproductive health in women of reproductive age: their local, proximal and distal regulatory roles

  2025cites this paper
• Menstrual Blood as a Diagnostic Specimen for Human Papillomavirus Genotyping and Genital Tract Infection Using Next-Generation Sequencing as a Novel Diagnostic Tool

  2024cites this paper
• Microbe-binding Antibodies in the Female Genital Tract: Associations with the Vaginal Microbiome and Genital Immunology.

  2024cites this paper
• Are violence, harmful alcohol/substance use and poor mental health associated with increased genital inflammation?: A longitudinal cohort study with HIV-negative female sex workers in Nairobi, Kenya

  2024cites this paper
• Bacterial vaginosis-driven changes in cervicovaginal immunity that expand the immunological hypothesis for increased HIV susceptibility

  2024cites this paper
• Vaccine value profile for herpes simplex virus.

  2024cites this paper
• Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer

  2024cites this paper
• Association between bacterial vaginosis with human papillomavirus in the United States (NHANES 2003–2004)

  2024cites this paper
• Interaction between Microbes and Host in Sow Vaginas in Early Pregnancy

  2023cites this paper
• The role of papillomavirus and herpesvirus infections in the origins and genesis of genital endometriosis. A literature review

  2023cites this paper
• Microbiota dynamics, metabolic and immune interactions in the cervicovaginal environment and their role in spontaneous preterm birth

  2023cites this paper
• The Interplay of Genital Herpes with Cellular Processes: A Pathogenesis and Therapeutic Perspective

  2023cites this paper
• Digital Commons@Becker Digital

  2023cites this paper
• Increased genital mucosal cytokines in Canadian women associate with higher antigen-presenting cells, inflammatory metabolites, epithelial barrier disruption, and the depletion of L. crispatus

  2023cites this paper
• The interplay between human papillomavirus and vaginal microbiota in cervical cancer development

  2023cites this paper
• Genital Herpes Simplex Virus Type 2 Suppression With Valacyclovir Is Not Associated With Changes in Nugent Score or Absolute Abundance of Key Vaginal Bacteria

  2023cites this paper
• Interactions between microbiota and cervical epithelial, immune, and mucus barrier

  2023influential citation
• Herpes Simplex Virus Type 2 Prevalence and Association with Inflammatory Cytokines Among Sexual and Gender Minorities Living With and Without HIV-1 from Lagos, Nigeria

  2023cites this paper
• Treatment Success Following Standard Antibiotic Treatment for Bacterial Vaginosis Is Not Associated With Pretreatment Genital Immune or Microbial Parameters

  2023cites this paper
• Novel Vaccine Strategies and Factors to Consider in Addressing Health Disparities of HPV Infection and Cervical Cancer Development among Native American Women

  2022cites this paper
• Insertive condom-protected and condomless vaginal sex both have a profound impact on the penile immune correlates of HIV susceptibility

  2022cites this paper
• Immune milieu and microbiome of the distal urethra in Ugandan men: impact of penile circumcision and implications for HIV susceptibility

  2022cites this paper
• Cervicovaginal DNA Virome Alterations Are Associated with Genital Inflammation and Microbiota Composition

  2022cites this paper
• Network-Based Differences in the Vaginal and Bladder Microbial Communities Between Women With and Without Urgency Urinary Incontinence

  2022cites this paper
• Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial

  2022cites this paper
• Considerations for Choosing Soluble Immune Markers to Determine Safety of Novel Vaginal Products

  2022cites this paper
• Immune parameters of HIV susceptibility in the female genital tract before and after penile-vaginal sex

  2022cites this paper
• The Penis, the Vagina and HIV Risk: Key Differences (Aside from the Obvious)

  2022cites this paper
• Female Genital Fibroblasts Diminish the In Vitro Efficacy of PrEP against HIV

  2022cites this paper
• The female reproductive tract microbiotas, inflammation, and gynecological conditions

  2022cites this paper
• The place of virome in women’s reproductive health

  2022cites this paper
• Concomitant and productive genital infections by HSV-2 and HPV in two young women: A case report

  2022cites this paper
• Effect of vaginal flora on clinical outcome of frozen embryo transfer

  2022cites this paper
• Optimizing the vaginal microbiome as a potential strategy to reduce heterosexual HIV transmission

  2022cites this paper
• The role of the genital microbiota in the acquisition and pathogenesis of sexually transmitted infections

  2022cites this paper
• Beyond bacterial vaginosis: vaginal lactobacilli and HIV risk

  2021influential citation
• Bacterial vaginosis and health-associated bacteria modulate the immunometabolic landscape in 3D model of human cervix

  2021cites this paper
• The role of microbiota in pathogenesis and development of viral infections

  2021cites this paper
• The Female Reproductive Tract Microbiome—Implications for Gynecologic Cancers and Personalized Medicine

  2021cites this paper
• Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis

  2021cites this paper
• Insertive vaginal sex has a profound impact on the penile immune correlates of HIV susceptibility

  2021cites this paper
• The female reproductive tract virome: understanding the dynamic role of viruses in gynecological health and disease.

  2021cites this paper
• Microbiomes: Some Philosophical and Sociological Implications

  2021cites this paper
• Penile bacteria associated with HIV seroconversion, inflammation, and immune cells

  2021cites this paper
• HIV susceptibility in women: The roles of genital inflammation, sexually transmitted infections and the genital microbiome.

  2021cites this paper
• The Complex Link between the Female Genital Microbiota, Genital Infections, and Inflammation

  2021cites this paper
• Distinction between vaginal and cervical microbiota in high-risk human papilloma virus-infected women in China

  2020cites this paper
• Vaginal microbiota, immune response and some sexually transmitted infections: mechanisms of interaction and regulation of the vaginal ecosystem

  2020cites this paper
• Detection of Herpes Simplex Virus Type 2 and Some Bacterial Vaginosis Isolated from Women in Hilla City/ Iraq

  2020cites this paper
• Vaginal microbiome-hormonal contraceptive interactions associate with the mucosal proteome and HIV acquisition

  2020influential citation
• Factors associated with HIV susceptibility in the female genital tract

  2020cites this paper
• How integral is the α4β7 integrin to HIV transmission?

  2020cites this paper
• Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health

  2020cites this paper
• Comparative Analysis of Lower Genital Tract Microbiome Between PCOS and Healthy Women

  2020cites this paper
• The Vaginal Virome—Balancing Female Genital Tract Bacteriome, Mucosal Immunity, and Sexual and Reproductive Health Outcomes?

  2020cites this paper
• Herpes simplex virus: global infection prevalence and incidence estimates, 2016

  2020cites this paper
• The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility

  2020cites this paper
• Gardnerella vaginalis as a Cause of Bacterial Vaginosis: Appraisal of the Evidence From in vivo Models

  2020cites this paper
• Gardnerella and Prevotella: Co-conspirators in the Pathogenesis of Bacterial Vaginosis.

  2019cites this paper
• Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling

  2019cites this paper
• Impact of Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Dual Infection on Female Genital Tract Mucosal Immunity and the Vaginal Microbiome.

  2019cites this paper
• Host-vaginal microbiota interactions in the pathogenesis of bacterial vaginosis.

  2019cites this paper
• Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis

  2019cites this paper
• Gardnerella and vaginal health: the truth is out there.

  2019cites this paper
• The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission

  2019cites this paper
• Interplay among Vaginal Microbiome, Immune Response and Sexually Transmitted Viral Infections

  2019cites this paper
• Pre-exposure prophylaxis differentially alters circulating and mucosal immune cell activation in HSV-2 seropositive women.

  2019cites this paper
• Microbiota and Its Role on Viral Evasion: Is It With Us or Against Us?

  2019cites this paper
• A pro-inflammatory CD8+ T-cell subset patrols the cervicovaginal tract

  2019cites this paper
• Pre-exposure prophyla xis differentially alters circulating and mucosal immune cell activation in herpes simplex virus type 2 seropositive women

  2019cites this paper
• The vaginal microbiome amplifies sex hormone‐associated cyclic changes in cervicovaginal inflammation and epithelial barrier disruption

  2018cites this paper
• Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.

  2018influential citation
• Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases?

  2018cites this paper
• Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women

  2018cites this paper
• Caractérisation et diversité des mécanismes du syndrome de mortalité affectant les juvéniles de Crassostrea gigas

  2018cites this paper
• Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women

  2018cites this paper
• The vaginal eukaryotic DNA virome and preterm birth

  2018cites this paper
• Pathogens, microbiome and the host: emergence of the ecological Koch's postulates

  2018cites this paper
• A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan Africa

  2017cites this paper
• Spontaneous clearance of the human papilloma virus as a result of suppressive therapy with acyclic nucleosides of a recurrent herpes-viral infection

  2017cites this paper
• The biology of how circumcision reduces HIV susceptibility: broader implications for the prevention field

  2017cites this paper
• Summer 2017

  2017cites this paper